PBYI EBITDA Margin
Puma Biotechnology Inc · EBITDA Margin
PBYI EBITDA Margin
Latest reported19.53%period ending
PBYI TTM EBITDA Margin (3740.11% → 19.53%)
TTM ebitda margin
High-resolution chart · PNG
PBYI ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 19.5318% | |
| 19.8039% | |
| 23.3576% | |
| 23.6605% | |
| 26.5859% | |
| 23.4864% | |
| 20.8602% | |
| 19.9894% | |
| 15.6637% | |
| 17.9638% | |
| 19.856% | |
| 12.5036% | |
| 9.3642% | |
| 11.7522% | |
| 9.4913% | |
| 14.1902% | |
| -6.4306% | |
| -13.2063% | |
| -2.092% | |
| -9.1842% | |
| -3.4622% | |
| -0.2915% | |
| -15.8629% | |
| -14.2949% | |
| -8.5629% | |
| -27.1494% | |
| -19.2769% | |
| -25.3352% | |
| -23.6563% | |
| -27.0892% | |
| -37.9436% | |
| -65.751% | |
| -138.045% | |
| -252.4636% | |
| -1,042.2589% | |
| -4,915.4517% | |
| 22,218.8462% | |
| 13,157.8016% | |
| 7,937.6323% | |
| 3,740.1133% |